Rani Therapeutics Holdings, Inc. (RANI)
Nasdaq: RANI · Pharmaceutical Preparations · San Jose, CA · filing with the SEC since 2021
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
| Report filed | Mar 26, 2026 | Mar 31, 2025 | Mar 20, 2024 | Mar 22, 2023 | Mar 31, 2022 | · |
| Revenue | 1,633 | 1,028 | 0 | 0 | 2,717 | 462 |
| Research and development | 20,205 | 26,682 | 39,624 | 36,607 | 26,482 | 12,044 |
| General and administrative | 19,738 | 23,946 | 26,475 | 26,844 | 27,834 | 4,962 |
| Total operating expenses | 39,943 | 54,342 | 66,099 | 63,451 | 54,316r | -17,006 |
| Operating income | -38,310 | -53,314 | -66,099 | -63,451 | -51,599 | -16,544 |
| Interest expense | 2,891 | 5,033 | 5,085 | 1,071 | 466 | 124 |
| Interest and investment income | · | · | · | · | 89 | 63 |
| Income before income taxes | · | · | -67,883 | -63,274 | -53,047 | -16,668 |
| Income tax expense | 0 | 0 | 0 | 70 | 41 | 35 |
| Net income including non-controlling interests | -40,950 | -56,584 | -67,883 | -63,344 | -53,088 | -16,703 |
| Net income to non-controlling interests | -11,277 | -26,566 | -33,913 | -32,756 | -44,757 | -16,703 |
| Net income | -29,673 | -30,018 | -33,970 | -30,588 | -8,331 | · |
| Earnings per share, basic | -0.45 | -1.05 | -1.33 | -1.28 | -0.43 | · |
| Earnings per share, diluted | -0.45 | -1.05 | -1.33 | -1.28 | -0.43 | · |
| Earnings per share, basic and diluted | · | · | · | · | -0.43 | · |
| Weighted average shares, basic | 66,138 | 28,476 | 25,505 | 23,817 | 19,534 | · |
| Weighted average shares, diluted | 66,138,000b | 28,476,000b | 25,505,000b | 23,817,000b | 19,534,000b | · |
| Weighted average shares, basic and diluted | · | · | · | · | 19,534,000 | · |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTaxResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest expense what its borrowing cost
us-gaap:InterestExpenseInterest and investment income what its cash and investments earned
us-gaap:InvestmentIncomeInterestIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income including non-controlling interests the whole group's profit, minority holders' share included
us-gaap:ProfitLossNet income to non-controlling interests the share that belongs to minority holders
us-gaap:NetIncomeLossAttributableToNoncontrollingInterestNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedEarnings per share, basic and diluted net income per share, where both counts are the same
us-gaap:EarningsPerShareBasicAndDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstandingWeighted average shares, basic and diluted the average count, where both counts are the same
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted